What CareMed Specialty Pharmacy does

CareMed Specialty Pharmacy is a US-based specialty pharmacy headquartered in New Hyde Park, NY, founded in 1964 and operating with 101-250 employees. The company exclusively dispenses and manages therapies for patients with rare, ultra-rare, and complex diseases, serving four distinct constituencies: patients, healthcare providers, pharmaceutical manufacturers, and payers/health plans. Its core offering combines specialty medication dispensing with clinical care coordination, adherence support, patient education, and 24/7 patient access, supported by a digital surface area that includes a branded patient portal/app (mycaremed), online bill pay via PatientNotebook, e-statement enrollment, and a public provider-referral intake workflow. CareMed maintains HIPAA compliance and references pharmacy accreditations, though specific specialty accreditations are not named in available sources.

The business model is anchored on revenue from dispensing high-cost specialty medications, with cash inflow generated through payer reimbursements, payer network contracts, and pharmaceutical manufacturer limited-distribution arrangements. The company operates on a sales-led go-to-market motion, acquiring patients through healthcare-provider referrals, pharma manufacturer mandates that channel prescription volume directly to CareMed, and payer network selection. National Specialty Pharmacy Provider/Partner designations secured from Travere Therapeutics (VANRAFIA, April 2025), Cytokinetics (MYQORZO, January 2026), and GSK (Exdensur, January 2026) are the most visible commercial assets and validate the company's distribution reach across the United States. Geographic reach is national, serving U.S. patients exclusively.

Ownership is not explicitly disclosed in available source material. The company appears to operate as a privately held, independent entity with no public listing, no disclosed institutional investors, and no recorded funding rounds. A footer link to pharmerica.com/compliance/ suggests a possible — but unconfirmed — corporate relationship with PharMerica. There are no disclosed APIs, integrations, AI capabilities, patents, trademarks, or M&A activity, and the leadership team is not enumerated in the source data, representing a notable information gap for due diligence.

Name

CareMed Specialty Pharmacy

Legal name

CareMed Specialty Pharmacy

Website

https://caremedsp.com

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

101–250 employees

Short description

CareMed Specialty Pharmacy is a US-based specialty pharmacy headquartered in New Hyde Park, NY, that dispenses and manages therapies for patients with rare, ultra-rare, and complex diseases via manufacturer partnerships, payer network contracts, and provider referrals.

Ownership category

akta.pro rank

Headquarters

HQ city

New Hyde Park

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Pharmacy Dispensing and Care Services: CareMed generates revenue by dispensing specialty medications to patients with rare, ultra-rare, and complex diseases, supported by clinical care coordination services. Revenue is derived from payer reimbursements, payer partnerships, and pharma manufacturer arrangements.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

CareMed Specialty Pharmacy dispenses specialty medications for rare, ultra-rare, and complex diseases while providing personalized clinical support, patient care coordination, and adherence services. The company operates as a national specialty pharmacy provider designated by pharmaceutical manufacturers (GSK, Cytokinetics, Travere Therapeutics) and partners with healthcare providers, payers, and health plans to deliver coordinated treatment across the patient journey.

Product overview

CareMed Specialty Pharmacy is a specialty pharmacy focused on rare, ultra-rare, and complex diseases. Their offering is a unified specialty pharmacy platform providing comprehensive services including: patient care with compassionate support and guidance throughout treatment journeys; provider support services for healthcare professionals; pharmaceutical commercialization partnerships for rare disease drug makers; and payer partnership programs. The platform manages specific specialty medications including Exdensur (depemokimab-ulaa), MYQORZO™ (aficamten), and VANRAFIA™ (atrasentan). Services are accessible through digital tools including a patient portal/app, online bill pay via PatientNotebook, and 24/7 customer support.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Care Services

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core.

• GSK (GlaxoSmithKline) — Exdensur (depemokimab-ulaa)coreStrategic or Co-development Partner · 29 January 2026CareMed was selected by GSK as a National Specialty Pharmacy Provider for Exdensur (depemokimab-ulaa), a specialty medication for a rare/ultra-rare condition. This designation channels prescriptions for this medication to CareMed and reflects a deep manufacturer-pharmacy partnership.
• Cytokinetics — MYQORZO (aficamten)coreStrategic or Co-development Partner · 12 January 2026CareMed was selected by Cytokinetics as a National Specialty Pharmacy Provider for MYQORZO (aficamten). This partnership positions CareMed as the preferred specialty pharmacy channel for the medication, supporting patient access and medication management.
• Travere Therapeutics — VANRAFIA (atrasentan)coreStrategic or Co-development Partner · 3 April 2025CareMed was selected by Travere Therapeutics as a National Specialty Pharmacy Partner for VANRAFIA (atrasentan). This partnership enables CareMed to dispense the medication and provide coordinated patient care services.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Soleo Health: Soleo Health is a national specialty pharmacy and home infusion provider serving patients with complex and rare conditions, offering clinical care coordination and limited distribution drug dispensing. It is a comparable mid-sized specialty pharmacy that competes with CareMed for manufacturer partnerships and rare disease referrals.
• PANTHERx Rare Pharmacy: PANTHERx Rare is a specialty pharmacy exclusively focused on rare and orphan disease therapies, dispensing high-cost specialty medications and providing clinical care coordination. It directly competes with CareMed for the same pharma manufacturer mandates and rare-disease patient population.
• Onco360 Oncology Pharmacy Solutions: Onco360 is a specialty pharmacy focused on oncology and rare disease therapies, providing care coordination and limited distribution drug dispensing. It competes with CareMed in the manufacturer-limited-distribution specialty space, though with a stronger oncology tilt.

Broad incumbents

• Biologics by McKesson: Biologics by McKesson is a specialty pharmacy focused on oncology and complex disease therapies, backed by McKesson's distribution scale. It is a comparable specialty dispensing and care-coordination platform competing for the same pharma manufacturer mandates as CareMed.
• CVS Specialty: CVS Specialty is the specialty pharmacy arm of CVS Health, offering nationwide dispensing and clinical management for rare and complex conditions. As a large integrated payer-PBM-pharmacy, it competes with CareMed for both pharma launch partnerships and payer in-network status.
• Accredo (Express Scripts): Accredo is one of the largest US specialty pharmacies, operated by Evernorth/Express Scripts and dispensing across rare, oncology, and chronic specialty conditions. It is a dominant incumbent that competes with CareMed for pharma manufacturer limited distribution mandates and payer network placement.
• Optum Specialty Pharmacy (formerly Diplomat): Optum Specialty Pharmacy, built around the legacy Diplomat specialty pharmacy franchise, dispenses rare and specialty medications under UnitedHealth Group's Optum umbrella. It is a direct national competitor to CareMed for limited distribution drugs and payer relationships.
• US Bioservices (AmerisourceBergen / Cencora): US Bioservices, part of Cencora (formerly AmerisourceBergen), is a specialty pharmacy dispensing rare, oncology, and chronic specialty therapies. It is a large incumbent competing for pharma mandates and payer network slots in the same space as CareMed.
• Walgreens Specialty Pharmacy: Walgreens Specialty Pharmacy (including its AllianceRx Walgreens Prime business) provides dispensing and clinical services for specialty and rare disease therapies nationwide. It competes with CareMed for limited distribution drug networks and offers broader retail-pharmacy integration.

Emerging players

• Trellis Rx (CPS Solutions): Trellis Rx operates embedded specialty pharmacy services within health systems, dispensing complex and specialty therapies in hospital and clinic settings. It represents an emerging distribution model that overlaps with CareMed's care-coordination value proposition, particularly around complex and rare disease therapies.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/CareMedSpecialtyPharmacy
• Instagraminstagram.com/caremedspecialtypharmacy

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CareMed Specialty Pharmacy